U.S. Markets open in 5 hrs 45 mins

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
464.02-4.52 (-0.96%)
At close: 4:00PM EDT
People also watch
ALXNBIIBCELGVRTXBMRN
  • s
    scharfpark
    scharfpark
    I wonder what the average prescription generates in revenue?
  • D
    Darren
    Darren
    XBIO and BCDA looking good and about make a leap.
  • s
    steven
    steven
    Thoughts about where it goes from here? Dupixent sales are picking up even after not meeting Sanofi's projections and some other analysts projections. Eylea sales are projected as strong through 2017. So what do others think about whether it heads up or goes back into the 300s again?
  • S
    Salut_Copains
    Salut_Copains
    losing the entire -$30 points from today's high at $498 to current price $468 now ---> no complaint but excitement
    stock will come down to retest the low $325 for the summer blues in August-September time frame to hop back in
  • .
    .
    .
    Is this really going to tank -$20 every day? SICKENING. -$20 x 2 just on SNY's earnings. Wonder how bad it'll be when REGN actually announces thier own earnings on Thursday??!?!!? -$100 in one day?
  • S
    Salut_Copains
    Salut_Copains
    stock has been sold off for the past couple days despite all the analysts saying "strong buy" or "buy"
    love this gem on sale perhaps she is heading to retest $325 in the near future after ER on thursday august 3rd
    what gives?
  • S
    Salut_Copains
    Salut_Copains
    wow pre-market hovering at $496 and quickly sold off at the opening bell ---> just exactly like biogen ER
  • s
    steven
    steven
    Hallako, the stock is down today because of disappointing Dupixent sales relative to what Sanofi had been expecting. It may very well go to 600 but not after this earnings report. Maybe in a year but this disappointing result could be quite significant since this was supposed to be a massive drug.
  • s
    steven
    steven
    This is for LP2013: You were wrong four days ago when you minimized the rate of sales for Dupixent in terms of how the market would read Regeneron earnings. Maybe next time you'll think about what some people have to say rather than insult them.
  • .
    .
    .
    WOW... -12 now. Barron's posted an article bashing REGN. They said the earnings were great and the guidance lift was good although Dupixent missed slightly. They bashed REGN over Dupixent saying all the gains were for that. Plus they also bashed the ADA agreement ending.
  • .
    .
    .
    Seriously!! How is this down -$6 now??? Didn't REGN beat estimates by $1?? +$20 to -$6. This is way worse then Biogens earnings.
  • S
    Sams
    Sams
    I guess not manipulation. Based on the volume , maybe just no interest.
  • .
    .
    .
    Who knew Bios were such garbage stocks? Only ONE of my bios didn't tank on earnings. Who knew the real money was in STAMPS??? If you don't believe me, check out STMP (Stamps.com) on thier earnings. Bios = bad pick on my part LOL... should have invested in stamps. I was hoping for FBIOX to recover close to $300, but I think that's out the window. Lowering my target to something more realistic :(.
  • H
    Haliako
    Haliako
    This stock will go to 600$!
  • M
    Mike T
    Mike T
    These prices ARE INSANE Price line $2000 and REGN was over $500 ! These prices are for #$%$ shooters at the boat!" This is 2008 all over again!
  • P
    Plarsonif
    Plarsonif
    Methinks the bad blood between Regeneron and Sanofi about to begin (or come to the open).
    Regeneron dropping Sanofi as partner. Hostile takeover by Sanofi?
  • S
    Sams
    Sams
    Didn't we see and hear the same pattern and speculation leading up to the last earnings report? I believe the stock (somehow) moved in the opposite of the expected direction.
  • .
    .
    .
    Amazing... Analysts are now saying we're going back to $360 and giving back all the gains since April. Are they serious? Because SNY missed the dupixent estimate by $3M???
  • .
    .
    .
    Tank to $450 tomorrow? and then another -$50+ on the actual earnings? Didn't this stock used to be $540 a month ago? #$%$... God Trump and his big mouth.
  • B
    B Yan
    B Yan
    This junk company may retest 100 soon.